218 related articles for article (PubMed ID: 7414314)
1. [Therapy of ventricular tachyarrhythmia with disopyramid phosphate].
Steinbrunn W; Mattmann H; Enrico JF; Engel U
Schweiz Med Wochenschr; 1980 Jun; 110(24):953-7. PubMed ID: 7414314
[TBL] [Abstract][Full Text] [Related]
2. [Antiarrhythmic effect of disopyramid retard versus propranolol retard in ventricular extrasystole].
Fechter P; Nager F
Schweiz Med Wochenschr; 1982 Dec; 112(51):1897-900. PubMed ID: 6187065
[TBL] [Abstract][Full Text] [Related]
3. [Antiarrhythmic effect of disopyramide in ventricular extrasystole and auricular fibrillation].
Breithardt G; Haerten K; Seipel L
Z Kardiol; 1976 Aug; 65(8):713-23. PubMed ID: 61664
[TBL] [Abstract][Full Text] [Related]
4. Disopyramide-induced ventricular tachycardia.
Lo KS; Gantz KB; Stetson PL; Lucchesi BR; Pitt B
Arch Intern Med; 1980 Mar; 140(3):413-4. PubMed ID: 6153888
[TBL] [Abstract][Full Text] [Related]
5. [Quantitative evaluation of an antiarrhythmic therapy (disopyramide) in patients with frequent premature ventricular contractions (PVC) using a computer-assisted long-term ECG analysis system (author's transl)].
Weber H; Gloger D; Joskowicz G; Steinbach K
Z Kardiol; 1981 Jan; 70(1):13-21. PubMed ID: 7210773
[TBL] [Abstract][Full Text] [Related]
6. [Oral longterm therapy with disopyramide phosphate in patients with atrial and ventricular arrhythmias (author's transl)].
Stauch M; Grewe N
MMW Munch Med Wochenschr; 1977 Dec; 119(48):1563-6. PubMed ID: 74799
[TBL] [Abstract][Full Text] [Related]
7. [Dynamic electrocardiography evaluation of the effectiveness of prajmalium bitartrate, disopyramide and procainamide in patients with stabilized ventricular extrasystole].
Naccarella F; Del Corso P; Palmieri M; Cantelli I; Lentini G; Bracchetti D
G Ital Cardiol; 1981; 11(3):338-44. PubMed ID: 6169577
[TBL] [Abstract][Full Text] [Related]
8. [Antiarrhythmic action of disopyramide: a study of plasma levels].
Page A; Pic A; Besse P
Arch Mal Coeur Vaiss; 1979 Jul; 72(7):774-80. PubMed ID: 117775
[TBL] [Abstract][Full Text] [Related]
9. [Clinical studies of the antiarrhythmic efficacy of disopyramide phosphate (Norpace) (author's transl)].
Smith WS
Herz; 1978 Dec; 63(36):399-406. PubMed ID: 95482
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D
Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833
[TBL] [Abstract][Full Text] [Related]
11. [Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction].
Vogel M; Desoutter P; Bellanger P; Motté G; Welti JJ
Arch Mal Coeur Vaiss; 1976 Apr; 69(4):395-406. PubMed ID: 59581
[TBL] [Abstract][Full Text] [Related]
12. [Action of injectable disopyramide phosphate in the emergency treatment of ventricular tachycardia].
Valère PE; Guerot C; Castillo Fenoy A; Branvin E; Urbanczyk A; Tricot R
Coeur Med Interne; 1977; 16(2):285-92. PubMed ID: 891126
[No Abstract] [Full Text] [Related]
13. Correlation of disopyramide pharmacokinetics with efficacy in ventricular tachyarrhythmia.
Rangno RE; Warnica W; Ogilvie RI; Kreeft J; Bridger E
J Int Med Res; 1976; 4(1 Suppl):54-8. PubMed ID: 1026530
[No Abstract] [Full Text] [Related]
14. [Delayed-action disopyramide in the treatment of hyperkinetic ventricular arrhythmia. A randomized clinical comparative study vs immediate-action disopyramide].
Romanò M; Spinelli A; Cazzani E; Muzio L
Clin Ter; 1991 Jul; 138(1):13-9. PubMed ID: 1834395
[TBL] [Abstract][Full Text] [Related]
15. [Intravenously disopyramide phosphate administration for treatment of arrhythmias].
Aquaro G; Belli R; Pavia M; Rey L; Ravera A; Possavino G; Idone P
G Ital Cardiol; 1982; 12(7):509-19. PubMed ID: 7169147
[TBL] [Abstract][Full Text] [Related]
16. Long-term use of controlled-release disopyramide in patients with severe ventricular arrhythmias.
Paulk EA
Angiology; 1987 Feb; 38(2 Pt 2):198-204. PubMed ID: 3103494
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia].
Palmieri M; Capucci A; Lombardi G; Naccarella F; Bomba E; Bracchetti D
G Ital Cardiol; 1984 May; 14(5):357-9. PubMed ID: 6468817
[TBL] [Abstract][Full Text] [Related]
18. Recurrent ventricular tachycardia in man: evaluation of disopyramide therapy by intracardiac electrical stimulation.
Benditt DG; Pritchett EL; Wallace AG; Gallagher JJ
Eur J Cardiol; 1979 Apr; 9(4):255-76. PubMed ID: 428417
[No Abstract] [Full Text] [Related]
19. [Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)].
Chiariello M; Santinelli V; Ferro G; Tari MG; Stanislao M; Condorelli M
G Ital Cardiol; 1979; 9(9):975-83. PubMed ID: 520746
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of antiarrhythmic effects of disopyramide by multiclinical controlled double-blind methods.
Kimura E; Mashima S; Tanaka T
Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):338-43. PubMed ID: 7409935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
